1 Lal BK, Hobson RW. Management of ca rot id

restenosis[J]. J Cardiovasc Surg(Torino), 2006, 47:153.

2 Jing T, Wang H, Srivenugopal KS, et al. Conditional

expression of type 2 angiotensinⅡ receptor in rat

vascular smooth muscle cells reveals the interplay of

the angiotensin system in matrix metalloproteinase 2

expression and vascular remodeling[J]. Int J Mol Med,

2009, 24:103-110.

3 Huang Y, Salu K, Wang L, et al. Use of a tacrolimus

eluting stent to inhibit neointimal hyperplasia in a

porcine coronary model[J]. J Invasive Cardiol, 2005,

17:142-148.

4 Zhao YH. Coronary angioplasty restenosis after the

research[J]. Chin Modern Clinical Med J, 2008, 6:21-

22.

5 杨培, 吴庆华, 周晗, 等. 动脉支架放置术前白细胞计

数与锁骨下动脉支架远期通畅率的观察[J]. 中华全科

医师杂志, 2009, 8:458-459.

6 杨培, 陈忠, 姜军, 等. 影响锁骨下动脉支架远期通畅性

的危险因素分析[J]. 中华医学杂志, 2010, 90:1739-1742

7 Koizumi A, Kumakura H, Kanai H, et al. Tenyear

patency and factors causing restenosis after

endovascular treatment of iliac artery lesions[J]. Circ J,

2009, 73:860-866.

8 Iida O, Nanto S, Uemateu M, et al. Influence of stent

fracture on the long-term patency in the femoropopliteal

artery:experience of 4 years[J]. JACC

Cardiovasc Interv, 2009, 2:665-671.

9 李海伟, 徐克. 锁骨下动脉闭塞开通成功率的影响因

素分析[J]. 介入放射性杂志, 2009, 18:653-655.

10 俞恒锡, 张建, 汪中镐, 等. 锁骨下动脉阻塞支架置入

50例临床分析[J]. 中华微创外科杂志, 2006, 6:827-

829.

11 李郁芳, 蒋初明. 经皮血管内支架治疗锁骨下动脉狭

窄性疾病[J]. 介入放射性杂志, 2008, 17:132-136.

12 李志永, 张梦彩, 刘恋. 股动脉及桡动脉双入路再通

锁骨下动脉闭塞的临床研究[J]. 中国卒中杂志, 2014,

9:26-29.

13 Michael TT, Banerjee S, Brilakis ES. Use of the

Frontrunner catheter to cross a chronic total occlusion

of the left subclavian artery[J]. Hellenic J Cardiol,

2011, 52:86-90.

14 张曦彤, 夏永辉, 刘大伟, 等. 介入治疗右锁骨下动脉

狭窄或闭塞的技术与疗效评价[J]. 中华放射学杂志,

2012, 46:1011-1013.